|
[1]
|
Pui, C.H., Yang, J.J., Hunger, S.P., Pieters, R., Schrappe, M., Biondi, A., et al. (2015) Childhood Acute Lymphoblastic Leukemia: Progress through Collaboration. Journal of Clinical Oncology, 33, 2938-2948. [Google Scholar] [CrossRef]
|
|
[2]
|
兰洋, 陈晓娟, 邹尧, 阮敏, 竺晓凡. CCLG-ALL2008方案治疗10岁以上儿童及青少年急性淋巴细胞白血病的疗效分析[J]. 中国当代儿科杂志, 2019, 21(5): 405-410.
|
|
[3]
|
蔡娇阳, 王宁玲, 蒋慧, 沈树红, 薛惠良, 陈静, 等. 儿童急性淋巴细胞白血病2005方案多中心远期临床报告[J]. 中华儿科杂志, 2018, 56(7): 511-517.
|
|
[4]
|
Radu, L.E., Colita, A., Pasca, S., Tomuleasa, C., Popa, C., Serban, C., et al. (2020) Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases. Frontiers in Oncology, 10, Article No. 923. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Landau, H. and Lamanna, N. (2006) Clinical Manifestations and Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults. Current Hematologic Malignancy Reports, 1, 171-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Koukourakis, M.I., Giatromanolaki, A. and Sivridis, E. (2003) Lactate Dehydrogenase Isoenzymes 1 and 5: Differential Expression by Neoplastic and Stromal Cells in Non-Small Cell Lung Cancer and Other Epithelial Malignant Tumors. Tumor Biology, 24, 199-202. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
吴永霞, 王海燕, 王伟. 骨髓增生异常综合征和急性白血病病人血清TPO、LDH的测定及临床意义[J]. 中国实验血液学杂志, 2010, 18(3): 671-674.
|
|
[8]
|
Miao, P., Sheng, S., Sun, X., Liu, J. and Huang, G. (2013) Lactate Dehydrogenase A in Cancer: A Promising Target for Diagnosis and Therapy. IUBMB Life, 65, 904-910. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Benadiba, J., Rosilio, C., Nebout, M., Heimeroth, V., Neffati, Z., Popa, A., et al. (2017) Iron Chelation: An Adjuvant Therapy to Target Metabolism, Growth and Survival of Murine PTEN-Deficient T Lymphoma and Human T Lymphoblastic Leukemia/Lymphoma. Leukemia & Lymphoma, 58, 1433-1445. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Hagag, A.A., Badraia, I.M., Abdelmageed, M.M., Hablas, N.M., Hazzaa, S.M.E. and Nosair, N.A. (2018) Prognostic Value of Transferrin Receptor-1 (CD71) Expression in Acute Lymphoblastic Leukemia. Endocrine, Metabolic & Immune Disorders-Drug Targets, 18, 610-617. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
刘青, 蒋慧, 孙恒娟, 宋以菊, 包黎明. 儿童急性淋巴细胞白血病细胞遗传学特征分析[J]. 中华血液学杂志, 2012, 33(4): 282-285.
|
|
[12]
|
张小珍, 乐萍, 霍小春, 黄慧, 黎文婷, 郭智彬. 178例儿童急性淋巴细胞白血病细胞与分子遗传学特征研究[J]. 中国优生与遗传杂志, 2014, 22(9): 33-35+49.
|
|
[13]
|
Rubnitz, J.E., Wichlan, D., Devidas, M., Shuster, J., Linda, S.B., Kurtzberg, J., et al. (2008) Prospective Analysis of TEL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study. Journal of Clinical Oncology, 26, 2186-2191. [Google Scholar] [CrossRef]
|
|
[14]
|
高静, 胡绍燕, 卢俊, 何海龙, 王易, 赵文理, 等. TEL/AML1基因阳性急性淋巴细胞白血病患儿CCLG-ALL-2008方案疗效分析[J]. 临床儿科杂志, 2017, 35(5): 325-330.
|
|
[15]
|
Ismail, S.I., Naffa, R.G., Yousef, A.M. and Ghanim, M.T. (2014) Incidence of bcr-abl Fusion Transcripts in Healthy Individuals. Molecular Medicine Reports, 9, 1271-1276. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Gao, C., Zhao, X.X., Li, W.J., Cui, L., Zhao, W., Liu, S.G., et al. (2012) Clinical Features, Early Treatment Responses, and Outcomes of Pediatric Acute Lymphoblastic Leukemia in China with or without Specific Fusion Transcripts: A Single Institutional Study of 1,004 Patients. American Journal of Hematology, 87, 1022-1027. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Rives, S., Estella, J., Gómez, P., López-Duarte, M., de Miguel, P.G., Verdeguer, A., et al. (2011) Intermediate Dose of Imatinib in Combination with Chemotherapy Followed by Allogeneic Stem Cell Transplantation Improves Early Outcome in Paediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia (ALL): Results of the Spanish Cooperative Group SHOP Studies ALL-94, ALL-99 and ALL-2005. British Journal of Haematology, 154, 600-611. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Tomizawa, D., Kato, M., Takahashi, H., Fujimura, J., Inukai, T., Fukushima, T., et al. (2015) Favorable Outcome in Non-Infant Children with MLL-AF4-Positive Acute Lymphoblastic Leukemia: A Report from the Tokyo Children’s Cancer Study Group. International Journal of Hematology, 102, 602-610. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
张琳琳. E2 A-PBX1融合基因阳性儿童急性淋巴细胞白血病发病机制及复发相关因素[J]. 国际儿科学杂志, 2018, 45(10): 776-778+782.
|
|
[20]
|
Pui, C.H., Sandlund, J.T., Pei, D., Campana, D., Rivera, G.K., Ribeiro, R.C., et al. (2004) Improved Outcome for Children with Acute Lymphoblastic Leukemia: Results of Total Therapy Study XIIIB at St Jude Children’s Research Hospital. Blood, 104, 2690-2696. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Jovanovska, A., Martinova, K., Kocheva, S., Trajkova-Antevska, Z., Coneska-Jovanova, B., Panovska-Stavridis, I., et al. (2019) Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia. Open Access Macedonian Journal of Medical Sciences, 7, 2818-2823.
|
|
[22]
|
Wei, W., Chen, X., Zou, Y., Chang, L., An, W., Wan, Y., et al. (2015) Prediction of Outcomes by Early Treatment Responses in Childhood T-Cell Acute Lymphoblastic Leukemia: A Retrospective Study in China. BMC Pediatrics, 15, Article No. 80. [Google Scholar] [CrossRef] [PubMed]
|